European Commission approves Merck acquisition of Millipore
The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck.
The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck. The $7.2 billion acquisition was announced in March and this approval keeps it on course for completion later this year.
The commission ruled that although the parties are both active in the life science business, they focus on different markets. In a statement they said that while Millipore supplies inputs for the research, development and production of biological drugs created through biological processes, Merck's inputs mainly serve in the research, development and production of products created through chemical processes. It concluded, “the transaction is largely complementary.”
For more information on the companies visit their websites, www.merck.de and www.millipore.com
Troubleshooting Everywhere! An Assortment of Topics from Pittcon 2025
April 5th 2025In this installment of “LC Troubleshooting,” Dwight Stoll touches on highlights from Pittcon 2025 talks, as well as troubleshooting advice distilled from a lifetime of work in separation science by LCGC Award winner Christopher Pohl.
This information is supplementary to the article “Accelerating Monoclonal Antibody Quality Control: The Role of LC–MS in Upstream Bioprocessing”, which was published in the May 2025 issue of Current Trends in Mass Spectrometry.
